home / stock / cocp / cocp news


COCP News and Press, Cocrystal Pharma Inc. From 05/15/23

Stock Information

Company Name: Cocrystal Pharma Inc.
Stock Symbol: COCP
Market: NASDAQ
Website: cocrystalpharma.com

Menu

COCP COCP Quote COCP Short COCP News COCP Articles COCP Message Board
Get COCP Alerts

News, Short Squeeze, Breakout and More Instantly...

COCP - Cocrystal Pharma GAAP EPS of -$0.64 misses by $0.05

2023-05-15 09:58:13 ET Cocrystal Pharma press release ( NASDAQ: COCP ): Q1 GAAP EPS of -$0.64 misses by $0.05 . Cocrystal reported unrestricted cash as of March 31, 2023 of $34.0 million, compared with $37.1 million as of December 31, 2022. Research and development...

COCP - Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs

BOTHELL, Wash., May 15, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the three months ended March 31, 2023 and provides updates on its antiviral pipeline, upcoming milestones and business activities. “Re...

COCP - Cocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference

BOTHELL, Wash., May 04, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces that new data from its CC-42344 Phase 1 influenza A Study was presented today by Sam Lee, Ph.D., President and co-CEO, at the 7 th Annual International Society for I...

COCP - Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors

BOTHELL, Wash., April 24, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the appointment of Fred Hassan to its Board of Directors, increasing its Board membership to six. Mr. Hassan’s distinguished 40-year career includes serving in se...

COCP - Cocrystal Pharma to Present New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference

BOTHELL, Wash., April 18, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the acceptance of an oral presentation containing new data from the Company’s CC-42344 Phase 1 influenza A study at the 7 th Annual International Society fo...

COCP - Penny Stocks To Buy Now? 4 Under $3 To Watch This Week

2023-04-10 10:28:20 ET Penny stocks are low-priced shares of companies that are generally smaller organizations. Though there can be exceptions to the rule, retail traders tend to lean toward these types of companies because of a history of significant potential. There aren’t many pl...

COCP - Cocrystal Pharma completes $4M equity offering priced ATM

2023-04-10 09:03:30 ET Cocrystal Pharma ( NASDAQ: COCP ) has announced the completion of a private placement of 2.03M shares of common stock at a price of $1.97/share for proceeds of $4M . Through this private placement Dr. Frost has increased his holdings and we...

COCP - PXD, TGTX and EH among pre-market gainers

2023-04-10 08:55:07 ET OncoSec Medical ( ONCS ) +65%.GlucoTrack ( GCTK ) +29%.Guardforce AI ( GFAI ) +22%.Eloxx Pharmaceuticals ( ELOX ) +15%.Cocrystal Pharma ( COCP ) +13% on completing $4 Million private placement priced at-the-market under Nasdaq rules.Enlivex Therape...

COCP - Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the completion of a private placement of 2,030,458 shares of common stock at a price of $1.97 per share for proceeds of $4.0 million. Investors in the private placement ...

COCP - Cocrystal Pharma GAAP EPS of -$4.77

2023-03-29 08:28:15 ET Cocrystal Pharma press release ( NASDAQ: COCP ): FY GAAP EPS of -$4.77. Cocrystal reported unrestricted cash of $37.1 million as of December 31, 2022 Net cash used in operating activities for 2022 was $21.4 million. The Company reported...

Previous 10 Next 10